Ronactolol
Names
IUPAC name
N-[4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl]-4-methoxybenzamide
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C20H26N2O4/c1-14(2)21-12-17(23)13-26-19-10-6-16(7-11-19)22-20(24)15-4-8-18(25-3)9-5-15/h4-11,14,17,21,23H,12-13H2,1-3H3,(H,22,24)
    Key: BPNZFFWEUGGXMC-UHFFFAOYSA-N
  • InChI=1/C20H26N2O4/c1-14(2)21-12-17(23)13-26-19-10-6-16(7-11-19)22-20(24)15-4-8-18(25-3)9-5-15/h4-11,14,17,21,23H,12-13H2,1-3H3,(H,22,24)
    Key: BPNZFFWEUGGXMC-UHFFFAOYAI
  • CC(C)NCC(COC1=CC=C(C=C1)NC(=O)C2=CC=C(C=C2)OC)O
Properties
C20H26N2O4
Molar mass 358.438 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Ronactolol is a beta adrenergic receptor antagonist.[1]

References

  1. ^ Mannucci, C; Caviglioli, G; Perico, A; Triolo, A (1992). "High-performance liquid chromatographic method for determination of ronactolol in urine and plasma: Evaluation of pharmacokinetic parameters in healthy humans". Journal of Pharmaceutical Sciences. 81 (6): 556–8. doi:10.1002/jps.2600810618. PMID 1355791.


Categories